20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with 14,15-dihydroxyeicosatrienoic acid in 4 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (14,15-dihydroxyeicosatrienoic acid) | Trials (14,15-dihydroxyeicosatrienoic acid) | Recent Studies (post-2010) (14,15-dihydroxyeicosatrienoic acid) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 48 | 1 | 19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norris, AW; Spector, AA; Van Der Veer, J; Widstrom, RL | 1 |
| Campbell, WB; Endsley, MP; Falck, JR; Gross, ER; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K | 1 |
| Falck, JR; Huang, Y; Kroetz, DL; Lin, ET; Ng, VY; Reddy, LM | 1 |
| Bass, A; Edin, ML; Ellis, K; Hinderliter, AL; Lee, CR; Lih, FB; Poloyac, SM; Schuck, RN; Stouffer, GA; Theken, KN; Tomer, KB; Tran, B; Wu, MC; Zeldin, DC | 1 |
4 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and 14,15-dihydroxyeicosatrienoic acid
| Article | Year |
|---|---|
Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acids; Binding, Competitive; Carrier Proteins; Epoxide Hydrolases; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Hydroxyeicosatetraenoic Acids; Kinetics; Ligands; Linoleic Acid; Models, Chemical; Myocardium; Neoplasm Proteins; Nerve Tissue Proteins; Oleic Acid; Rats; Recombinant Proteins; Solubility; Water | 2003 |
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Fatty Acids, Unsaturated; Female; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Miconazole; Microsomes; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones | 2004 |
Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Apolipoprotein A-I; Apolipoprotein A-II; Aryl Hydrocarbon Hydroxylases; Cell Line, Tumor; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Cytochrome P450 Family 4; Dose-Response Relationship, Drug; Eicosanoids; Epoxide Hydrolases; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Hydroxyeicosatetraenoic Acids; Peroxisome Proliferators; PPAR alpha; PPAR gamma; Pyrimidines; Rats; Rats, Sprague-Dawley; Response Elements; Retinoid X Receptors; RNA, Messenger; Steroid 16-alpha-Hydroxylase; Transcriptional Activation; Transfection | 2007 |
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Topics: 8,11,14-Eicosatrienoic Acid; Age Factors; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Eicosanoids; Epoxide Hydrolases; Female; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Male; Middle Aged; North Carolina; Obesity; Regression Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Smoking; Tandem Mass Spectrometry | 2012 |